Net profit of Fermenta Biotech reported to Rs 11.38 crore in the quarter ended September 2024 as against net loss of Rs 28.56 crore during the previous quarter ended September 2023. Sales rose 66.98% to Rs 95.03 crore in the quarter ended September 2024 as against Rs 56.91 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales95.0356.91 67 OPM %19.76-24.46 - PBDT17.97-15.70 LP PBT11.82-21.64 LP NP11.38-28.56 LP Powered by Capital Market - Live News

Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live News

Net loss of Fermenta Biotech reported to Rs 5.82 crore in the quarter ended June 2024 as against net profit of Rs 1.83 crore during the previous quarter ended June 2023. Sales declined 5.24% to Rs 78.13 crore in the quarter ended June 2024 as against Rs 82.45 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales78.1382.45 -5 OPM %1.0213.26 - PBDT0.198.16 -98 PBT-5.932.21 PL NP-5.821.83 PL Powered by Capital Market - Live News

Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live News

Fermenta Biotech announced that the Board of Directors of the Company at its meeting held on 27 May 2024, inter alia, have recommended the final dividend of Rs 1.25 per equity Share (i.e. 25%) , subject to the approval of the shareholders.Powered by Capital Market - Live News